Long-term safety of satralizumab in neuromyelitis optica spectrum disorder (NMOSD) from SAkuraSky and SAkuraStar

202259 citationsJournal Articlehybrid Open Access

Authors

ClinicalTrials.gov identifiers: NCT02028884 (SAkuraSky) and NCT02073279 (SAkuraStar).

Good health and well-being

Published in: Multiple Sclerosis and Related Disorders

Volume 66, pp. 104025-104025

Field-Weighted Citation Impact: 7.34